Guyer Charles Greg 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
2024-03-15+10,550→ 98,751 total - Tax Payment
Common Stock
2024-03-15$83.87/sh−20,424$1,712,961→ 78,327 total - Award
Stock Option (Right to Buy Common Stock)
2024-03-15+23,630→ 23,630 totalExercise: $83.87From: 2025-03-15Exp: 2034-03-14→ Common Stock (23,630 underlying)
Footnotes (2)
- [F1]Restricted stock units granted March 15, 2024. Price not applicable.
- [F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.